Humacyte: Health & Economic Perspective | Medical Office Live | March 6, 2019 | Chapel Hill, NC
38:49
Innovator, scientist and vascular surgeon, Jeff Lawson, MD, PhD, discusses the promise of regenerative medicine in transforming vascular access care and the health economic implications of Humacyl.
Innovator, scientist and vascular surgeon, Jeff Lawson, MD, PhD, discusses the promise of regenerative medicine in transforming vascular access care and the health economic implications of Humacyl.
Value Based Care | Chapel Hill, NC (March 2019) Similar Videos
-
Using Quality Data & Clinical Innovations to Improve ESCO Care | Medical Office Live | March 6, 2019 | Chapel Hill, NC
30:28
Nephrologist and value based care expert Terry Ketchersid, MD outlines the value of the transparency report and highlights clinical innovations that are driving success in value based care models.
-
Medicare Risk Adjustment and CKD in Value Based Care | Medical Office Live | March 6, 2019 | Chapel Hill, NC
29:37
Fresenius Health Partners’ Andy Aronson unravels the mystery of Medicare risk adjustment and talks about the impact of organizing CKD care in the ESCO environment.
-
Panel: Value Based Care & Changing Renal Landscape | Medical Office Live | March 6, 2019 | Chapel Hill, NC
45:55
Fresenius Kidney Care’s Chief Medical Officer Jeffrey L. Hymes leads a panel discussion with practicing nephrologists in ESCO markets exploring how value based care models have impacted the renal care landscape and implications for care delivery.
